跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 95 条关于
“LAMP2B”
全部
95
临床试验
67
药物
19
机构
0
资讯
9
2年前
Rocket Pharma Completes Enrollment in Phase 2 Trial of RP-A501 for Danon Disease
去年
Rocket Pharmaceuticals' Gene Therapy Shows Promise in Early Danon Disease Trial
5个月前
AAV Gene Therapy Pipeline Surpasses 250 Candidates as FDA Approvals and Late-Stage Trials Accelerate in 2026
8天前
FDA Aligns With Rocket Pharmaceuticals on 12-Patient Pivotal Phase 2 Design for Danon Disease Gene Therapy RP-A501
去年
AAV Gene Therapy Pipeline Expands with 180+ Companies Developing 250+ Treatments Despite Recent Setbacks
去年
FDA Grants Orphan Drug Designation to Modalis Therapeutics' MDL-101 for LAMA2-CMD
去年
MDL-101 Receives FDA Rare Pediatric Disease Designation for LAMA2-CMD Treatment
去年
Modalis Therapeutics Receives FDA Orphan Drug Designation for MDL-101 in LAMA2-CMD Treatment
2年前
Mindfulness Training Shows Promise in Managing Chronic Pain: LAMP Trial Results
